Self-Host
Tools / Inside Trading Tracker
Inside Trading Tracker
Track insider trading activity at publicly traded companies to understand how executives are trading their shares.
CERo Therapeutics Holdings, Inc. (CEROW) Insider Trading Activity
Healthcare • Biotechnology • 8 employees
CERo Therapeutics Holdings, Inc., an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer. Its lead development candidate is CER-1236, an autologous T cell therapy candidate for the treatment of hematologic malignancies. The company was incorporated in 2021 and is based in South San Francisco, California.
Total Value
$6,278,817,635.44
Total Shares
12,239,458
Average Trade Value
$570,801,603.22
Most Active Insider
Ehrlich Christopher B
Total Activity: $5,312,983,000
Largest Single Transaction
$5,312,983,000
by Ehrlich Christopher B on Sep 25, 2024
30-Day Activity
6 Transactions
Volume: 9,615,614 shares
Value: $783,826
|
Name
|
Position
|
Date
|
Shares
|
Value
|
Holdings
|
Type
|
|---|---|---|---|---|---|---|
| Dec 13, 2024 | 2,998,908 | $179,934 | 13,005,169 (-23.1%) | Sale | ||
| Dec 12, 2024 | 1,614,541 | $113,018 | 16,004,077 (-10.1%) | Sale | ||
| Dec 11, 2024 | 1,343,801 | $107,504 | 17,618,618 (-7.6%) | Sale | ||
| Dec 10, 2024 | 1,570,947 | $141,385 | 18,962,419 (-8.3%) | Sale | ||
| Dec 9, 2024 | 850,543 | $93,560 | 20,533,366 (-4.1%) | Sale | ||
| Dec 6, 2024 | 1,236,874 | $148,425 | 21,383,909 (-5.8%) | Sale | ||
| Oct 10, 2024 | 3,250,000 | $325,000 | 22,620,783 (-14.4%) | Sale | ||
|
10% Owner
|
Sep 25, 2024 | 532,486 | $55,538 | 21,067,956 (-2.5%) | Sale | |
|
Director
|
Sep 25, 2024 | 965,997 | $965,997,000 | 965,997 (+100.0%) | Exercise/Conversion | |
|
Director
|
Sep 25, 2024 | 19,358,578 | $1,002,000 | 19,607,313 (+98.7%) | Exercise/Conversion | |
|
Interim Chairman and CEO
Director, Officer
|
Sep 25, 2024 | 5,312,983 | $5,312,983,000 | 5,791,808 (+91.7%) | Exercise/Conversion |